# Serum Hepcidin Immunoassay - Laboratory to Marketplace

> **NCT03310736** · — · COMPLETED · sponsor: **Intrinsic LifeSciences, LLC** · enrollment: 494 (actual)

## Conditions studied

- Anemia, Iron Deficiency

## Interventions

- **DIAGNOSTIC_TEST:** Intrinsic Hepcidin IDx™ Test

## Key facts

- **NCT ID:** NCT03310736
- **Lead sponsor:** Intrinsic LifeSciences, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-30
- **Primary completion:** 2018-12-31
- **Final completion:** 2019-02-28
- **Target enrollment:** 494 (ACTUAL)
- **Last updated:** 2019-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03310736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03310736, "Serum Hepcidin Immunoassay - Laboratory to Marketplace". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03310736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*